Ghrelin Suppression by Octreotide in Prader-Willi

Clinical trial NCT01613495 · UNKNOWN

Trial details

NCT number: NCT01613495
Sponsor: Oregon Health and Science University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Prader Willis Syndrome

Start date: 2005-08-01
Primary completion: 2024-03-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.